D
Enliven Therapeutics, Inc. ELVN
$18.73 -$0.08-0.43% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 6.80M 6.17M 5.81M 5.78M 6.02M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 31.69M 26.90M 27.07M 24.60M 25.99M
Operating Income -31.69M -26.90M -27.07M -24.60M -25.99M
Income Before Tax -28.54M -23.18M -23.16M -19.72M -22.74M
Income Tax Expenses -- 0.00 -- 232.00K --
Earnings from Continuing Operations -28.54M -23.18M -23.16M -19.95M -22.74M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -28.54M -23.18M -23.16M -19.95M -22.74M
EBIT -31.69M -26.90M -27.07M -24.60M -25.99M
EBITDA -31.62M -26.82M -26.99M -24.53M -25.91M
EPS Basic -0.57 -0.46 -0.48 -0.42 -0.54
Normalized Basic EPS -0.36 -0.30 -0.30 -0.26 -0.34
EPS Diluted -0.57 -0.46 -0.48 -0.42 -0.54
Normalized Diluted EPS -0.36 -0.30 -0.30 -0.26 -0.34
Average Basic Shares Outstanding 50.05M 49.86M 48.27M 48.08M 42.05M
Average Diluted Shares Outstanding 50.05M 49.86M 48.27M 48.08M 42.05M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --